MetLife, Inc. (MET) quarterly income statement — complete revenue, gross profit & net income history
| Revenue | 19.07B | 23.81B | 16.88B | 17.18B | 18.26B | 18.44B | 18.3B | 17.49B | 15.9B | 19.03B | 15.87B | 16.62B |
| Revenue Growth % | 4.44% | 29.14% | -7.74% | -1.8% | 14.85% | -3.09% | 15.33% | 5.22% | 3.34% | 16.62% | -28.8% | 7.43% |
| Medical Costs & Claims | 11.97B | 16.54B | 13.94B | 12.64B | 13.54B | 13.58B | 12.85B | 13.1B | 11.41B | 15.85B | 13.21B | 14.1B |
| Medical Cost Ratio % | 62.76% | 69.47% | 82.6% | 73.57% | 74.15% | 73.62% | 70.23% | 74.91% | 71.75% | 83.32% | 83.25% | 84.82% |
| Gross Profit | 7.1B | 7.27B | 2.94B | 4.54B | 4.72B | 4.86B | 5.45B | 4.39B | 4.49B | 3.17B | 2.66B | 2.52B |
| Gross Margin % | 37.24% | 30.53% | 17.4% | 26.43% | 25.85% | 26.38% | 29.77% | 25.09% | 28.25% | 16.68% | 16.75% | 15.18% |
| Gross Profit Growth % | 50.46% | 49.47% | -46.08% | 3.46% | 5.1% | 53.25% | 104.93% | 73.92% | 94.37% | -16.56% | -22.26% | -15.19% |
| Operating Expenses | 5.6B | 6.15B | 1.73B | 3.56B | 3.37B | 3.48B | 3.45B | 3.19B | 3.45B | 2.23B | 2.12B | 2.09B |
| OpEx / Revenue % | 29.34% | 25.84% | 10.23% | 20.73% | 18.44% | 18.89% | 18.87% | 18.22% | 21.68% | 11.74% | 13.39% | 12.59% |
| Depreciation & Amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Combined Ratio % | 92.1% | 95.31% | 92.83% | 94.29% | 92.59% | 92.51% | 89.1% | 93.13% | 93.43% | 95.05% | 96.63% | 97.41% |
| Operating Income | 1.51B | 1.12B | 1.21B | 980M | 1.35B | 1.38B | 1.99B | 1.2B | 1.04B | 941M | 534M | 430M |
| Operating Margin % | 7.9% | 4.69% | 7.17% | 5.71% | 7.41% | 7.49% | 10.9% | 6.87% | 6.57% | 4.95% | 3.37% | 2.59% |
| Operating Income Growth % | 11.3% | -19.12% | -39.32% | -18.47% | 29.57% | 46.76% | 273.41% | 179.53% | 306.61% | -45.51% | -62.26% | -56.43% |
| EBITDA | 1.77B | 1.38B | 1.48B | 1.25B | 1.61B | 1.64B | 2.25B | 1.46B | 1.31B | 1.21B | 799M | 686M |
| EBITDA Margin % | 9.29% | 5.79% | 8.77% | 7.27% | 8.83% | 8.89% | 12.3% | 8.34% | 8.23% | 6.36% | 5.04% | 4.13% |
| Interest Expense | 265M | 263M | 271M | 269M | 258M | 259M | 257M | 257M | 264M | 269M | 265M | 256M |
| Non-Operating Income | -265M | -263M | -271M | -269M | -258M | -259M | -257M | -257M | -264M | -269M | -265M | -256M |
| Pretax Income | 1.51B | 1.12B | 1.21B | 980M | 1.35B | 1.38B | 1.99B | 1.2B | 1.04B | 941M | 534M | 430M |
| Pretax Margin % | 7.9% | 4.69% | 7.17% | 5.71% | 7.41% | 7.49% | 10.9% | 6.87% | 6.57% | 4.95% | 3.37% | 2.59% |
| Income Tax | 345M | 301M | 308M | 245M | 404M | 106M | 653M | 249M | 170M | 327M | 39M | 22M |
| Effective Tax Rate % | 22.89% | 26.95% | 25.45% | 25% | 29.84% | 7.68% | 32.75% | 20.72% | 16.27% | 34.75% | 7.3% | 5.12% |
| Net Income | 1.19B | 809M | 896M | 729M | 945M | 1.27B | 1.34B | 946M | 867M | 607M | 489M | 402M |
| Net Margin % | 6.21% | 3.4% | 5.31% | 4.24% | 5.17% | 6.89% | 7.33% | 5.41% | 5.45% | 3.19% | 3.08% | 2.42% |
| Net Income Growth % | 25.4% | -36.35% | -33.23% | -22.94% | 9% | 109.39% | 174.44% | 135.32% | 983.75% | -54.8% | -57.92% | -55.82% |
| EPS (Diluted) | 1.74 | 1.17 | 1.22 | 1.03 | 1.28 | 1.78 | 1.81 | 1.28 | 1.10 | 0.77 | 0.56 | 0.48 |
| EPS Growth % | 35.94% | -34.27% | -32.6% | -19.53% | 16.36% | 131.17% | 223.21% | 166.67% | 6045.25% | -53.61% | -59.12% | -55.56% |
| EPS (Basic) | 1.75 | 1.17 | 1.23 | 1.04 | 1.29 | 1.79 | 1.82 | 1.28 | 1.11 | 0.77 | 0.56 | 0.48 |
| Diluted Shares Outstanding | 655.7M | 664.96M | 669.1M | 675M | 687M | 697.9M | 703.7M | 714.7M | 728.4M | 745.46M | 755.5M | 769.6M |